Skip to content
WeighLab

JRNYS vs MyStart Health

Compare the prices, treatment options and tradeoffs that matter before you choose a GLP-1 program.

By The WeighLab Bench. Provider verification dates appear below.

JRNYS

Provider comparison

Insured shoppers who want brand-name GLP-1s with coaching, or a compounded option, and can accept learning the medication price only after a consultation.

Semaglutide / month
Not disclosed
Tirzepatide / month
Not disclosed
Index 51/100 · Grade CChecked October 2026
Check JRNYS pricing Read review

MyStart Health

Provider comparison

Shoppers who want a single flat all-inclusive monthly price and don't need semaglutide vs. tirzepatide broken out separately.

Semaglutide / month
$299/moCompounded
Tirzepatide / month
Not disclosed
Index 49/100 · Grade CChecked August 2026

Compounded drugs are not FDA-approved. Understand the medication options.

Check MyStart Health pricing Read review

We may earn a commission if you sign up through a provider link, at no extra cost to you. Compensation does not change scores. How we earn money.

The comparison in brief

JRNYS has the higher Cost-Efficiency Index: 51/100 versus 49/100. That is a value comparison under our published methodology, not a measure of medical suitability or a guarantee of results.

The better fit depends on what is included in your quote. A lower advertised price can require prepayment, apply to a starting dose or leave out a separate fee.

How the comparison is scored

Costs & coverage

Published prices with their terms intact. Annual estimates account for billing frequency and known fixed required fees; they are not a treatment quote.

JRNYS

MyStart Health

Semaglutide / month
JRNYS: Not disclosed
MyStart Health: $299/moCompounded
Tirzepatide / month
JRNYS: Not disclosed
MyStart Health: Not disclosed
Semaglutide / year (modeled)
JRNYS: —
MyStart Health: $3,588
Tirzepatide / year (modeled)
JRNYS: —
MyStart Health: —
State availability
JRNYS: Coverage not published
MyStart Health: Coverage not published
Oral / sublingual option listed
JRNYS: Not listed
MyStart Health: Not listed
Brand-name access listed
JRNYS: Yes
MyStart Health: Not confirmed
Provider facts checked
JRNYS: October 2026
MyStart Health: August 2026

Comparing different billing plans? See what a GLP-1 monthly price can leave out, or calculate the monthly cost.

Which program fits your priorities?

The strengths and limitations behind each provider's score. Read the full review before deciding.

JRNYS

Insured shoppers who want brand-name GLP-1s with coaching, or a compounded option, and can accept learning the medication price only after a consultation.

Reasons to consider it

  • Brand-name GLP-1s (Wegovy, Ozempic, Zepbound, Mounjaro, Saxenda) through your insurance, plus compounded semaglutide and tirzepatide
  • The membership band ($89–$169/mo) is published before intake and is banded openly by level of coach support
  • Medical visits, daily monitoring and 1-on-1 coaching are included in the membership at every tier

What to weigh up

  • The membership is overhead, not a medication price: medication is priced separately and confirmed only after a provider consultation
  • The only medication figure shown is a compounded tirzepatide microdose card 'from $216/m'; no standard semaglutide or tirzepatide price is published
  • The $89 first telehealth fee isn't refunded once a doctor reviews your profile, and canceling needs 7 days' notice before the next billing date
Check JRNYS pricing Read the full JRNYS review

MyStart Health

Shoppers who want a single flat all-inclusive monthly price and don't need semaglutide vs. tirzepatide broken out separately.

Reasons to consider it

  • Genuinely all-inclusive stated price: physician evaluations, unlimited follow-ups, bloodwork, and shipping are explicitly bundled into the $299 figure with 'no hidden fees'
  • Price-lock guarantee explicitly covers dose increases — the FAQ states the price won't rise 'even if your dosage increases'
  • Named Chief Medical Advisor (Dr. Ritu Chopra, Beverly Hills MD)

What to weigh up

  • Does not publish separate pricing for semaglutide vs. tirzepatide — $299 is a single blended program price, so it's unclear which drug (or whether both) that figure actually buys
  • A sitewide 'Lifetime 25% Off' promo banner is not reconciled against the stated '$299/month excluding any discounts' base price or the price-lock guarantee's 'excluding our first-time discount' exception — genuinely ambiguous what a patient ends up paying long-term
  • No compounding pharmacy named, only generic 'US facilities that meet strict USP standards'

Regulatory note: the FDA issued a warning letter to Matthew Stern, CEO MyStart Health LLC. in September 2025. We still list and link to MyStart Health; you should know the letter is on the public record before you decide.

Compounded drugs are not FDA-approved. Understand the medication options.

Check MyStart Health pricing Read the full MyStart Health review

Explore the six scoring factors

Scores run from 0 to 100. A higher factor score reflects our published value criteria; it is not a clinical endorsement.

JRNYSMyStart Health
Normalized Cost/Month
JRNYS:
45/100
MyStart Health:
35/100
Price Transparency
JRNYS:
54/100
MyStart Health:
78/100
Nationwide Access
JRNYS:
24/100
MyStart Health:
24/100
Formulation Options
JRNYS:
58/100
MyStart Health:
53/100
Clinical Oversight
JRNYS:
84/100
MyStart Health:
78/100
Contract Flexibility
JRNYS:
55/100
MyStart Health:
31/100

Before you sign up

  • Confirm your totalAsk about dose changes, membership, labs, shipping and cancellation terms.
  • Check treatment accessState coverage and medical eligibility can differ by medication and formulation.
  • Understand the medicationCompare compounded and brand-name options. Compounded drugs are not FDA-approved.

Keep comparing

Alternatives to JRNYSAlternatives to MyStart Health
More provider matchups
CoreAge Rx vs JRNYSCoreAge Rx vs MyStart Health
Choose a different comparison

Provider information reflects public disclosures at the verification dates shown. Prices and availability change; confirm current terms before paying. This comparison is for information, not medical advice. A licensed clinician determines whether treatment is appropriate.